Literature DB >> 12392381

Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis.

Jeffrey A Wilken1, Robert Berkowitz, Robert Kane.   

Abstract

BACKGROUND AND
OBJECTIVE: The adverse effects of untreated seasonal allergic rhinitis (AR) on performance in the workplace, school, and home are poorly understood. To delineate more clearly the impact and consequences of the disease on performance, the effect of symptomatic AR on vigilance and a wide range of cognitive functions was investigated.
METHODS: A battery of automated neuropsychological tests was administered to asymptomatic adult subjects with histories of AR. Subjects were randomized to either a symptomatic or to an asymptomatic group. Subjects in the symptomatic group were exposed to ragweed pollen in a controlled exposure setting until they demonstrated predetermined severities of AR symptoms. Subjects in the asymptomatic group were not exposed to ragweed pollen in the environmental unit and retained a minimum symptom profile. The battery of cognitive measures was re-administered to both groups.
RESULTS: AR had major adverse impacts on measures of vigilance. Further, AR adversely affected a broad range of cognitive functions. Specifically, subjects with AR symptoms demonstrated longer response times and decreased efficiency on measures of working memory, psychomotor speed, reasoning/computation, and divided attention as compared with asymptomatic subjects.
CONCLUSIONS: In addition to decreased vigilance, AR was associated with decrements in speed and efficiency across several cognitive domains. This is similar to findings in research on medications and medical conditions that cause sedation. Findings may represent a link between AR and poor productivity/personal safety among AR sufferers. This suggests that these results have implications with regard to public health.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12392381     DOI: 10.1016/S1081-1206(10)62038-8

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  19 in total

1.  Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial.

Authors:  Joris C Verster; A Marit de Weert; Saskia I R Bijtjes; Mounir Aarab; Armand W A A van Oosterwijck; Erik J E Eijken; Marinus N Verbaten; Edmund R Volkerts
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

Review 2.  The safety and efficacy of desloratadine for the management of allergic disease.

Authors:  William E Berger
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Allergic rhinitis: relationships with anxiety and mood syndromes.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2011-07

Review 4.  Congestion and sleep impairment in allergic rhinitis.

Authors:  Timothy J Craig; Amir Sherkat; Sahar Safaee
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

Review 5.  Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis Research.

Authors:  Michelle L North; Mena Soliman; Terry Walker; Lisa M Steacy; Anne K Ellis
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

Review 6.  Latest developments in the management of allergic rhinitis.

Authors:  Alvin M Sanico
Journal:  Clin Rev Allergy Immunol       Date:  2004-12       Impact factor: 8.667

7.  Psychological stress and its relationship with persistent allergic rhinitis.

Authors:  Diaa El Din Mohamed El Hennawi; Mohamed Rifaat Ahmed; Alaa Mohamed Farid
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-08       Impact factor: 2.503

8.  Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases.

Authors:  Matteo Ferrando; Diego Bagnasco; Valeria Roustan; Giorgio Walter Canonica; Fulvio Braido; Ilaria Baiardini
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

9.  Allergy: a risk factor for suicide?

Authors:  Teodor T Postolache; Hirsh Komarow; Leonardo H Tonelli
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

10.  Cognitive dysfunction associated with pain and quality of life in chronic rhinosinusitis.

Authors:  George S Tarasidis; Adam S DeConde; Jess C Mace; Shaelene Ashby; Timothy L Smith; Richard R Orlandi; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2015-06-22       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.